The present invention relates to a pharmaceutical composition containing a calcium ion antagonist of pharmaceutical dosage, a statin lipid-lowering drug of medicinal dosage, a nicotinic acid in pharmaceutical dosage and a pharmaceutically acceptable carrier. The invention provides a pharmaceutical composition can effectively prevent or delay treatment, hypertension and dyslipidemia, can synergistically protect endothelial cell function, synergistic antioxidant effect and synergetically protect heart and kidney function, cooperate to prevent or delay the formation of atherosclerotic plaque, together with reduced incidence of stroke. Through the implementation of the present invention, the specific drug composition provided to the patient can improve patient compliance, make the patient easy to take medicine and lower medical expenses, and has a better market prospect. The invention belongs to the field of pharmacy.
【技术实现步骤摘要】
【技术保护点】
一种药物组合物,包括: (1)药用剂量的钙离子拮抗剂、钙离子拮抗剂异构体、钙离子拮抗剂活性代谢产物或钙离子拮抗剂可药用盐中的一种; (2)药用剂量的他汀类降脂药物、他汀类降脂药物异构体、他汀类降脂药物活性代谢产物或他汀类降脂药物 可药用盐中的一种; (3)药用剂量的烟酸;及 (4)药剂学上可接受的载体。 其中,所述钙离子拮抗剂选自氨氯地平、硝苯地平、非洛地平、尼群地平、阿折地平、尼莫地平、尼卡地平、拉西地平、尼索地平、尼伐地平、伊拉地平、巴尼地平、 西尼地平、尼鲁地平、地尔硫卓、维拉帕米中的一种;所述他汀类降脂药物选自 ...
【技术特征摘要】
【专利技术属性】
技术研发人员:王文艳,秦献辉,于多,陈光亮,徐希平,
申请(专利权)人:北京奥萨医药研究中心有限公司,深圳奥萨医药有限公司,
类型:发明
国别省市:11[中国|北京]
还没有人留言评论。发表了对其他浏览者有用的留言会获得科技券。